Investigational Site Number 840001

Dallas, Texas 75235

0 studies enrolling now · 9 studies all time

What they study most

Diabetes Mellitus, Type 2, RA, Rheumatoid Arthritis, Type 2 Diabetes, Type 2 Diabetes Mellitus

Studies at this site

• Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND) — Completed
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes Mellitus on Basal Plus Mealtime Insulin — Completed
• Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 2 Diabetes on Basal Insulin With Oral Antidiabetic Therapy — Completed
• Comparison of the Safety and Efficacy of HOE901-U300 With Lantus in Older Patients With Type2 Diabetes Insufficiently Controlled on Their Current Antidiabetic Medications — Completed
• Evaluation of Sarilumab (SAR153191/REGN88) on Top of Methotrexate in Rheumatoid Arthritis Patients — Completed
• To Evaluate Sarilumab - SAR153191 (REGN88) - Auto-injector Device In Patients With Rheumatoid Arthritis — Completed
• Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients — Completed
• Sarilumab Effect on the Pharmacokinetics of Simvastatin — Completed
• Efficacy Assessment of Insulin Glargine Versus LiraglutidE After Oral Agents Failure — Completed